Literature DB >> 17373735

Decreased fragile histidine triad expression in colorectal cancer and its association with apoptosis inhibition.

Jie Cao1, Xiao-Ping Chen, Wang-Lin Li, Jie Xia, Hong Du, Wei-Biao Tang, Hui Wang, Xi-Wen Chen, Huan-Qing Xiao, Yu-Yuan Li.   

Abstract

AIM: To detect the expression of fragile histidine triad (FHIT) in normal colorectal tissue, colorectal adenoma and colorectal cancer (CRC) tissue, and to analyze its relationship with the clinicopathological features of CRC, and apoptosis-associated proteins (Bcl-2, Bax, survivin) and apoptosis in colorectal cancer.
METHODS: FHIT mRNA analysis was performed by nested reverse transcription-polymerase chain reaction (RT-PCR) assay. Tissue microarray (TMA) was established to detect the expression of FHIT, Bcl-2, Bax and survivin genes in 80 CRC tissue specimens, 16 colorectal adenoma tissue specimens and 16 hemorrhoid (PPH) tissue specimens during the same period of time as the control. Citrate-microwave-SP was used as immunohistochemical method. The relationship between clinicopathological factors, such as differentiation grades and 5-year survival rate was observed. TUNEL assay was used to detect the apoptosis index in 80 CRC tissue specimens.
RESULTS: Ten out of 26 (38.5%) CRC tissue specimens expressed aberrant FHIT transcripts, none of the aberrant FHIT transcripts was observed in the matched normal tissue and colorectal adenoma tissue by nested RT-PCR assay. The positive rate of FHIT gene expression in normal colorectal tissue, colorectal adenoma and carcinoma tissue was 93.75%, 68.75% and 46.25%, respectively. Clinicopathological analysis of patients showed that the decreased FHIT gene expression was not associated with age, sex, serum CEA levels, tumor site and size, histological classification. However, the expression of FHIT was correlated with differentiation grades, pathological stages, lymph node metastases and 5-year survival rate after operation. The positive rate of apoptosis-associated proteins (Bax, Bcl-2 and survivin) in CRC tissue was 72.50%, 51.25% and 77.50%, respectively. The expression of these apoptosis-associated proteins in CRC tissue was correlated with the expression of FHIT. The mean apoptosis index in FHIT negative tumors was significantly lower than that in FHIT positive tumors (5.41 +/- 0.23 vs 0.56 +/- 0.10, P < 0.01).
CONCLUSION: The FHIT gene plays an important role in the regulation of apoptosis and decreased FHIT expression plays a key role in the initiation and progression of colorectal carcinoma.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17373735      PMCID: PMC4146863          DOI: 10.3748/wjg.v13.i7.1018

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  23 in total

1.  Immunoprofiles of 11 biomarkers using tissue microarrays identify prognostic subgroups in colorectal cancer.

Authors:  Thomas Knösel; Anna Emde; Karsten Schlüns; Yuan Chen; Karsten Jürchott; Matthias Krause; Manfred Dietel; Iver Petersen
Journal:  Neoplasia       Date:  2005-08       Impact factor: 5.715

2.  Loss of fragile histidine triad expression in colorectal carcinomas and premalignant lesions.

Authors:  X P Hao; J E Willis; T G Pretlow; J S Rao; G T MacLennan; I C Talbot; T P Pretlow
Journal:  Cancer Res       Date:  2000-01-01       Impact factor: 12.701

3.  Aberration of FHIT gene is associated with increased tumor proliferation and decreased apoptosis-clinical evidence in lung and head and neck carcinomas.

Authors:  K Pavelić; S Krizanac; T Cacev; M P Hadzija; S Radosević; I Crnić; S Levanat; S Kapitanović
Journal:  Mol Med       Date:  2001-07       Impact factor: 6.354

4.  Evaluation of the FHIT gene in colorectal cancers.

Authors:  S Thiagalingam; N A Lisitsyn; M Hamaguchi; M H Wigler; J K Willson; S D Markowitz; F S Leach; K W Kinzler; B Vogelstein
Journal:  Cancer Res       Date:  1996-07-01       Impact factor: 12.701

5.  Clinicopathologic features and FHIT gene expression in sporadic colorectal adenocarcinomas.

Authors:  C Luceri; F Guglielmi; C De Filippo; G Caderni; E Mini; A Biggeri; C Napoli; F Tonelli; F Cianchi; P Dolara
Journal:  Scand J Gastroenterol       Date:  2000-06       Impact factor: 2.423

Review 6.  Survivin, versatile modulation of cell division and apoptosis in cancer.

Authors:  Dario C Altieri
Journal:  Oncogene       Date:  2003-11-24       Impact factor: 9.867

7.  The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t(3;8) breakpoint, is abnormal in digestive tract cancers.

Authors:  M Ohta; H Inoue; M G Cotticelli; K Kastury; R Baffa; J Palazzo; Z Siprashvili; M Mori; P McCue; T Druck; C M Croce; K Huebner
Journal:  Cell       Date:  1996-02-23       Impact factor: 41.582

8.  Bad, a heterodimeric partner for Bcl-XL and Bcl-2, displaces Bax and promotes cell death.

Authors:  E Yang; J Zha; J Jockel; L H Boise; C B Thompson; S J Korsmeyer
Journal:  Cell       Date:  1995-01-27       Impact factor: 41.582

9.  FHIT gene alterations in head and neck squamous cell carcinomas.

Authors:  L Virgilio; M Shuster; S M Gollin; M L Veronese; M Ohta; K Huebner; C M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-03       Impact factor: 11.205

Review 10.  Bcl-2 and the regulation of programmed cell death.

Authors:  J C Reed
Journal:  J Cell Biol       Date:  1994-01       Impact factor: 10.539

View more
  7 in total

1.  Correlation of aberrant expression of CD133 with FHIT and malignant phenotype of colorectal adenocarcinoma.

Authors:  Hong Li; Po Zhao; Yang Lu; Yali Lu
Journal:  Int J Colorectal Dis       Date:  2012-02-09       Impact factor: 2.571

2.  Fhit down-regulation is an early event in pancreatic carcinogenesis.

Authors:  Matteo Fassan; Borislav Rusev; Vincenzo Corbo; Pierluigi Gasparini; Claudio Luchini; Caterina Vicentini; Andrea Mafficini; Salvatore Paiella; Roberto Salvia; Ivana Cataldo; Aldo Scarpa; Kay Huebner
Journal:  Virchows Arch       Date:  2017-03-13       Impact factor: 4.064

3.  Reduced FHIT expression is associated with mismatch repair deficient and high CpG island methylator phenotype colorectal cancer.

Authors:  Rabeah Abbas Al-Temaimi; Sindhu Jacob; Waleed Al-Ali; Diana Ann Thomas; Fahd Al-Mulla
Journal:  J Histochem Cytochem       Date:  2013-06-24       Impact factor: 2.479

4.  Aberrant crypt focus and fragile histidine triad protein in sporadic colorectal carcinoma.

Authors:  Kim Vaiphei; Aruna Rangan; Rajinder Singh
Journal:  World J Gastrointest Oncol       Date:  2012-12-15

5.  Coordinate loss of fragile gene expression in pancreatobiliary cancers: correlations among markers and clinical features.

Authors:  Mark Bloomston; Jeffrey Kneile; Matthew Butterfield; Mary Dillhoff; Peter Muscarella; E Christopher Ellison; W Scott Melvin; Carlo M Croce; Flavia Pichiorri; Kay Huebner; Wendy L Frankel
Journal:  Ann Surg Oncol       Date:  2009-05-12       Impact factor: 5.344

6.  Integrated Genomic Analysis of Pancreatic Ductal Adenocarcinomas Reveals Genomic Rearrangement Events as Significant Drivers of Disease.

Authors:  Stephen J Murphy; Steven N Hart; Geoffrey C Halling; Sarah H Johnson; James B Smadbeck; Travis Drucker; Joema Felipe Lima; Fariborz Rakhshan Rohakhtar; Faye R Harris; Farhad Kosari; Subbaya Subramanian; Gloria M Petersen; Timothy D Wiltshire; Benjamin R Kipp; Mark J Truty; Robert R McWilliams; Fergus J Couch; George Vasmatzis
Journal:  Cancer Res       Date:  2015-12-16       Impact factor: 12.701

7.  Livin serves as a prognostic marker for mid-distal rectal cancer and a target of mid-distal rectal cancer treatment.

Authors:  Qi-Biao Su; Lai-You Wang; Gui-Ning Wei; Li-Zhen Liao; Jie Zhao; Hong-Jun Liu; Yu-Long Shi; Le-Ping Li; Chen-Sheng Li
Journal:  Oncol Lett       Date:  2017-10-20       Impact factor: 2.967

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.